Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{171410,
        author = {Mulaparthi Ajay Ratnam and Relangi Sirisha and Inti Indu and Relangi Harshitha Valli and Isukapudi Sravani and Dr.V.Bhaskara Raju and Puli Esther and Dr.P.Narayana Raju},
        title = {SPANLASTICS AS INNOVATIVE DRUG DELIVERY SYSTEM},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {7},
        pages = {3290-3295},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=171410},
        abstract = {Innovative drug delivery methods based on nano carriers, spanlastics are intended to improve the therapeutic effectiveness and bioavailability of pharmaceuticals. They are elastic, nanosized vesicles formed by a combination of non-ionic surfactants and cholesterol, offering flexibility, stability, and controlled drug release. Spanlastics are particularly effective in delivering hydrophobic drugs and can penetrate biological barriers like the skin and mucous membranes. Their elasticity allows them to deform and pass through narrow pores, making them suitable for transdermal, ophthalmic, and other site-specific drug delivery applications. This technology has shown potential in improving drug solubility, reducing side effects, and ensuring sustained therapeutic effects.},
        keywords = {Nano size vesciles, Spanlastics, transdermal, ophthalmic.},
        month = {December},
        }